SCHEMBL2118557

SCHEMBL2118557

CCCCCCCCCC(CCCCCC)OC(=O)C(CCCCCC)CCCCCCCC

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.50
ZDHHC7 Q9NXF8 1/20 0.47
CA1 P00915 1/20 0.46
FAAH O00519 1/20 0.45
LMNA P02545 3/20 0.44
GRIK1 P39086 2/20 0.44
GRIK2 Q13002 2/20 0.44
ALDH1A1 P00352 1/20 0.44
GPR84 Q9NQS5 7/20 0.44
FFAR1 O14842 1/20 0.44
MAPT P10636 2/20 0.43
MAPK1 P28482 1/20 0.43
LCK P06239 1/20 0.42
PPARD Q03181 1/20 0.42
ZDHHC20 Q5W0Z9 1/20 0.42
ZDHHC2 Q9UIJ5 1/20 0.42
SLC1A2 P43004 1/20 0.42
SLC1A1 P43005 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL297378 1.00 CA2 (0.50) CA2ZDHHC7CA1FAAHLMNA
SCHEMBL5355144 1.00 CA2 (0.50) CA2ZDHHC7CA1FAAHLMNA
SCHEMBL17514315 1.00 CA2 (0.50) CA2ZDHHC7CA1FAAHLMNA
SCHEMBL20512291 0.98 CA2 (0.53) CA2ZDHHC7CA1FAAHLMNA
SCHEMBL29459306 0.98 CA2 (0.53) CA2ZDHHC7CA1FAAHLMNA
SCHEMBL24711085 0.94 CA2 (0.46) CA2ZDHHC7CA1FAAHLMNA
SCHEMBL28982556 0.92 CA2 (0.47) CA2ZDHHC7CA1FAAHLMNA
SCHEMBL22471739 0.92 CA2 (0.56) CA2ZDHHC7CA1FAAHLMNA
SCHEMBL18204386 0.92 CA2 (0.47) CA2ZDHHC7CA1FAAHLMNA
SCHEMBL1490741 0.91 CA2 (0.59) CA2ZDHHC7CA1FAAHLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11439583-B2 Protective skin compositions AMANTIN EXPERTS (FR) 2022-09-13 US disclosed
EP-3177265-B1 PROTECTIVE SKIN COMPOSITIONS AMANTIN EXPERTS (FR) 2022-04-13 EP disclosed
US-11191704-B2 Compositions and methods for controlled moisturizing and release of active ingredients AMANTIN EXPERTS (FR) 2021-12-07 US disclosed
US-9932368-B2 Peptides for the stimulation of collagen formation INFINITEC ACTIVOS S.L. (ES) 2018-04-03 US disclosed
EP-3116894-B1 NOVEL ANTIMICROBIAL PEPTIDES AND THEIR APPLICATION INFINITEC ACTIVOS S L (ES) 2018-02-28 EP disclosed
US-20170246090-A1 COMPOSITIONS AND METHODS FOR CONTROLLED MOISTURIZING AND RELEASE OF ACTIVE INGREDIENTS AMANTIN EXPERTS (FR) 2017-08-31 US disclosed
US-9745346-B2 Antimicrobial peptides and their application INFINITEC ACTIVOS S.L (ES) 2017-08-29 US disclosed
US-20170224603-A1 PROTECTIVE SKIN COMPOSITIONS AMANTIN EXPERTS (FR) 2017-08-10 US disclosed
EP-3182955-A1 COMPOSITIONS AND METHODS FOR CONTROLLED MOISTURIZING AND RELEASE OF ACTIVE INGREDIENTS Amantin Experts (FR) 2017-06-28 EP disclosed
EP-3177265-A1 PROTECTIVE SKIN COMPOSITIONS Amantin Experts (FR) 2017-06-14 EP disclosed
CN-103341701-A Flux for soft soldering SHENMAO ELECTRONIC TECHNOLOGY CHONGQING CO LTD 2013-10-09 CN disclosed
US-20120093896-A1 USE OF NANODISPERSIONS TO PROTECT WATER-SOLUBLE INGREDIENTS IN COSMETIC END FORMULATIONS CIBA CORPORATION (US) 2012-04-19 US disclosed
US-20100111884-A1 UV ABSORBER FORMULATIONS CIBA CORPORATION (US) 2010-05-06 US disclosed
EP-2170250-A1 USE OF NANODISPERSIONS TO PROTECT WATER-SOLUBLE INGREDIENTS IN COSMETIC END FORMULATIONS BASF SE (DE) 2010-04-07 EP disclosed
EP-2099530-A1 UV ABSORBER FORMULATIONS Ciba Holding Inc. (CH) 2009-09-16 EP disclosed
US-20090196894-A1 Self Tanning Composition CIBA CORP. 2009-08-06 US disclosed
EP-2026746-A2 SELF TANNING COMPOSITION Ciba Holding Inc. (CH) 2009-02-25 EP disclosed
WO-2009016064-A1 USE OF NANODISPERSIONS TO PROTECT WATER-SOLUBLE INGREDIENTS IN COSMETIC END FORMULATIONS BASF SE (CH) 2009-02-05 WO disclosed
WO-2008080892-A1 UV ABSORBER FORMULATIONS CIBA HOLDING INC. (CH) 2008-07-10 WO disclosed
WO-2007137958-A2 SELF TANNING COMPOSITION CIBA HOLDING INC. (CH) 2007-12-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100111884-A1 UV ABSORBER FORMULATIONS C1R, C1S, C9 CA2 2370/4885ZDHHC7 2903/4885CA1 2345/4885
US-20090196894-A1 Self Tanning Composition C9, KRT18, F12 CA2 4251/4885ZDHHC7 2620/4885CA1 4188/4885
US-20120093896-A1 USE OF NANODISPERSIONS TO PROTECT WATER-SOLUBLE INGREDIENTS IN COSMETIC END FORMULATIONS CUTA, PROC, RBP1 CA2 2253/4885ZDHHC7 2339/4885CA1 4037/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.